{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:07:21Z","timestamp":1777486041072,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The objectives of this study were to describe the clinical and etiologic profile and outcomes of children with hemophagocytic lymphohistiocytosis (HLH) in a tertiary care hospital in South India.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a combined 2-year prospective (2017 to 2018) and 5-year retrospective (2012 to 2016) descriptive study in which children from birth to 18 years who satisfied the HLH-2004 diagnostic criteria were included. Case details from patient records were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifty-three cases were enrolled of which 20 were prospective and 33 were retrospective. Fever, hepatomegaly, anemia, and hyperferritinemia were the common presentations. Infectious triggers were found in 33 (62%) cases. Five cases were secondary to rheumatic diseases, and 8 were primary HLH. Bacterial (14 cases) followed by viral infections (10 cases) were the leading triggers. Scrub typhus (6 cases) and dengue (4 cases) were the most common infectious agents. Major complications include febrile neutropenia (38%) and multiorgan dysfunction (26%). One child developed secondary malignancy. The most frequently used immunosuppressive drug for the treatment of HLH was steroid (70%), while 28% of cases recovered with only supportive therapy. The overall mortality was 41%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Infections were the most common triggers for HLH of which tropical infectious agents constituted the majority. Treatment with steroids alone or regimens without cytotoxic drugs may result in resolution of secondary HLH with mild to moderate disease activity. Without stem cell transplant, primary HLH has a high mortality rate.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000001791","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T23:07:45Z","timestamp":1585264065000},"page":"e281-e285","source":"Crossref","is-referenced-by-count":18,"title":["Hemophagocytic Lymphohistiocytosis in Children: Clinical Profile and Outcome"],"prefix":"10.1097","volume":"42","author":[{"given":"Anna C.","family":"Simon","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinnaiah Govindhareddy","family":"Delhi Kumar","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debdatta","family":"Basu","sequence":"additional","affiliation":[{"name":"Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran","family":"Ramesh Kumar","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Castillo","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MPH.0b013e3181f84a52","article-title":"Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010","volume":"33","author":"Imashuku","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"e26264","DOI":"10.1002\/pbc.26264","article-title":"Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: a retrospective multicenter study","volume":"64","author":"Xu","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13312-011-0020-2","article-title":"Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India","volume":"48","author":"Ramachandran","year":"2011","journal-title":"Indian Pediatr"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5644\/ama2006-124.49","article-title":"Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent","volume":"41","author":"Rajagopala","year":"2012","journal-title":"Acta Med Acad"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 Study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/postgradmedj-2012-130955","article-title":"A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment","volume":"89","author":"Nair","year":"2013","journal-title":"Postgrad Med J"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/01.inf.0000190043.48182.31","article-title":"Secondary hemophagocytic lymphohistiocytosis in Turkish children","volume":"24","author":"Gurgey","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20230918","first-page":"54","article-title":"Infections and HLH\u2014experience from a tertiary care centre","volume":"67","author":"Ray","year":"2019","journal-title":"J Assoc Physicians India"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/JBM.S92438","article-title":"A retrospective analysis of 56 children with hemophagocytic lymphohistiocytosis","volume":"7","author":"Wang","year":"2016","journal-title":"J Blood Med"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00296-011-2291-2","article-title":"Infection-associated haemophagocytic lymphohistiocytosis: a case series using steroids only protocol for management","volume":"33","author":"Giri","year":"2013","journal-title":"Rheumatol Int"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5492\/wjccm.v7.i6.73","article-title":"Intensive care unit complications and outcomes of adult patients with hemophagocytic lymphohistiocytosis: a retrospective study of 16 cases","volume":"7","author":"Kapoor","year":"2018","journal-title":"World J Crit Care Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:49:14Z","timestamp":1695012554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001791","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}